Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1984 Sep;37(9):961–974. doi: 10.1136/jcp.37.9.961

Clinical and biological significance of aneuploidy in human tumours.

M L Friedlander, D W Hedley, I W Taylor
PMCID: PMC498910  PMID: 6381555

Abstract

Aneuploidy is a well recognised feature of human tumours, but the investigation of its biological and clinical significance has been hampered by technological constraints. Quantitative DNA analysis reflects the total chromosomal content of tumour cells and can now be determined rapidly and reliably using flow cytometry; this has resulted in renewed interest in its potential clinical applications. This article reviews the accumulating evidence that tumour ploidy reflects the biological behaviour of a large number of tumour types and that diploid tumours in particular have a relatively good prognosis. The measurement of tumour ploidy is likely to become a valuable adjunct to the clinical and histopathological assessment of cancers.

Full text

PDF
961

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams L. R., Dahlgren S. E. Cytophotometric measurements of the DNA content of lung tumours. Acta Pathol Microbiol Scand. 1968;72(4):561–574. doi: 10.1111/j.1699-0463.1968.tb00469.x. [DOI] [PubMed] [Google Scholar]
  2. Andreeff M., Darzynkiewicz Z., Sharpless T. K., Clarkson B. D., Melamed M. R. Discrimination of human leukemia subtypes by flow cytometric analysis of cellular DNA and RNA. Blood. 1980 Feb;55(2):282–293. [PubMed] [Google Scholar]
  3. Atkin N. B., Kay R. Prognostic significance of modal DNA value and other factors in malignant tumours, based on 1465 cases. Br J Cancer. 1979 Aug;40(2):210–221. doi: 10.1038/bjc.1979.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Atkin N. B. Modal DNA value and chromosome number in ovarian neoplasia. A clinical and histopathologic assessment. Cancer. 1971 May;27(5):1064–1073. doi: 10.1002/1097-0142(197105)27:5<1064::aid-cncr2820270510>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  5. Atkin N. B. Modal deoxyribonucleic acid value and survival in carcinoma of the breast. Br Med J. 1972 Jan 29;1(5795):271–272. doi: 10.1136/bmj.1.5795.271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Atkin N. B., Pickthall V. J. Chromosomes 1 in 14 ovarian cancers. Heterochromatin variants and structural changes. Hum Genet. 1977 Aug 31;38(1):25–33. doi: 10.1007/BF00295804. [DOI] [PubMed] [Google Scholar]
  7. Atkin N. B. Prognostic significance of ploidy level in human tumors. I. Carcinoma of the uterus. J Natl Cancer Inst. 1976 May;56(5):909–910. doi: 10.1093/jnci/56.5.909. [DOI] [PubMed] [Google Scholar]
  8. Auer G. U., Arrhenius E., Granberg P. O., Fox C. H. Comparison of DNA distributions in primary human breast cancers and their metastases. Eur J Cancer. 1980 Feb;16(2):273–278. doi: 10.1016/0014-2964(80)90160-7. [DOI] [PubMed] [Google Scholar]
  9. Auer G. U., Caspersson T. O., Gustafsson S. A., Humla S. A., Ljung B. M., Nordenskjöld B. A., Silfverswärd C., Wallgren A. S. Relationship between nuclear DNA distribution and estrogen receptors in human mammary carcinomas. Anal Quant Cytol. 1980 Dec;2(4):280–284. [PubMed] [Google Scholar]
  10. Auer G. U., Caspersson T. O., Wallgren A. S. DNA content and survival in mammary carcinoma. Anal Quant Cytol. 1980 Sep;2(3):161–165. [PubMed] [Google Scholar]
  11. Auer G., Tribukait B. Comparative single cell and flow DNA analysis in aspiration biopsies from breast carcinomas. Acta Pathol Microbiol Scand A. 1980 Nov;88(6):355–358. doi: 10.1111/j.1699-0463.1980.tb02506.x. [DOI] [PubMed] [Google Scholar]
  12. BADER S., TAYLOR H. C., Jr, ENGLE E. T. Deoxyribonucleic acid (DNA) content of human ovarian tumors in relation to histological grading. Lab Invest. 1960 Jul-Aug;9:443–459. [PubMed] [Google Scholar]
  13. Baisch H., Otto U., König K., Klöppel G., Köllermann M., Linden W. A. DNA content of human kidney carcinoma cells in relation to histological grading. Br J Cancer. 1982 Jun;45(6):878–886. doi: 10.1038/bjc.1982.140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Barlogie B., Drewinko B., Schumann J., Göhde W., Dosik G., Latreille J., Johnston D. A., Freireich E. J. Cellular DNA content as a marker of neoplasia in man. Am J Med. 1980 Aug;69(2):195–203. doi: 10.1016/0002-9343(80)90379-4. [DOI] [PubMed] [Google Scholar]
  15. Barlogie B., Hittelman W., Spitzer G., Trujilo J. M., Hart J. S., Smallwood L., Drewinko B. Correlation of DNA distribution abnormalities with cytogenetic findings in human adult leukemia and lymphoma. Cancer Res. 1977 Dec;37(12):4400–4407. [PubMed] [Google Scholar]
  16. Barlogie B., Johnston D. A., Smallwood L., Raber M. N., Maddox A. M., Latreille J., Swartzendruber D. E., Drewinko B. Prognostic implications of ploidy and proliferative activity in human solid tumors. Cancer Genet Cytogenet. 1982 May;6(1):17–28. doi: 10.1016/0165-4608(82)90017-6. [DOI] [PubMed] [Google Scholar]
  17. Barlogie B., Latreille J., Freireich E. J., Fu C. T., Mellard D., Meistrich M., Andreeff M. Characterization of hematologic malignancies by flow cytometry. Blood Cells. 1980;6(4):719–744. [PubMed] [Google Scholar]
  18. Barlogie B., Raber M. N., Schumann J., Johnson T. S., Drewinko B., Swartzendruber D. E., Göhde W., Andreeff M., Freireich E. J. Flow cytometry in clinical cancer research. Cancer Res. 1983 Sep;43(9):3982–3997. [PubMed] [Google Scholar]
  19. Bichel P., Frederiksen P., Kjaer T., Thommesen P., Vindelov L. L. Flow microfluorometry and transrectal fine-needle biopsy in the classification of human prostatic carcinoma. Cancer. 1977 Sep;40(3):1206–1211. doi: 10.1002/1097-0142(197709)40:3<1206::aid-cncr2820400334>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  20. Bichel P., Poulsen H. S., Andersen J. Estrogen receptor content and ploidy of human mammary carcinoma. Cancer. 1982 Nov 1;50(9):1771–1774. doi: 10.1002/1097-0142(19821101)50:9<1771::aid-cncr2820500921>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  21. Bjelkenkrantz K., Herder A., Gröntoft O., Stål O. Cytophotometric characterization of the WHO grades of transitional cell neoplasms. Pathol Res Pract. 1982 Jul;174(1-2):68–77. doi: 10.1016/S0344-0338(82)80029-0. [DOI] [PubMed] [Google Scholar]
  22. Bloomfield C. D., Arthur D. C., Frizzera G., Levine E. G., Peterson B. A., Gajl-Peczalska K. J. Nonrandom chromosome abnormalities in lymphoma. Cancer Res. 1983 Jun;43(6):2975–2984. [PubMed] [Google Scholar]
  23. Blöndal T., Lindgren A. Fluorescence cytophotometric measurements of nuclear DNA in adenocarcinoma of the lung; relation of proliferative activity and DNA ploidy to prognosis. Anal Quant Cytol. 1982 Sep;4(3):225–232. [PubMed] [Google Scholar]
  24. Bosman F. T., Groen F. C., van der Ploeg M. DNA content and chromosome number of a heteroploid human tumour cell line. Histochemistry. 1979 Apr 3;60(2):181–188. doi: 10.1007/BF00495753. [DOI] [PubMed] [Google Scholar]
  25. Brodsky W. Y., Uryvaeva I. V. Cell polyploidy: its relation to tissue growth and function. Int Rev Cytol. 1977;50:275–332. doi: 10.1016/s0074-7696(08)60100-x. [DOI] [PubMed] [Google Scholar]
  26. Bunn P. A., Jr, Krasnow S., Makuch R. W., Schlam M. L., Schechter G. P. Flow cytometric analysis of DNA content of bone marrow cells in patients with plasma cell myeloma: clinical implications. Blood. 1982 Mar;59(3):528–535. [PubMed] [Google Scholar]
  27. Bunn P. A., Jr, Whang-Peng J., Carney D. N., Schlam M. L., Knutsen T., Gazdar A. F. DNA content analysis by flow cytometry and cytogenetic analysis in mycosis fungoides and Sézary syndrome. J Clin Invest. 1980 Jun;65(6):1440–1448. doi: 10.1172/JCI109808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Busch C., Engberg A., Norlén B. J., Stenkvist B. Malignancy grading of epithelial bladder tumours. Reproducibility of grading and comparison between forceps biopsy, aspiration biopsy and exfoliative cytology. Scand J Urol Nephrol. 1977;11(2):143–148. doi: 10.3109/00365597709179707. [DOI] [PubMed] [Google Scholar]
  29. Böhm N., Sandritter W. DNA in human tumors: a cytophotometric study. Curr Top Pathol. 1975;60:151–219. doi: 10.1007/978-3-642-66215-7_5. [DOI] [PubMed] [Google Scholar]
  30. Cairns J. The origin of human cancers. Nature. 1981 Jan 29;289(5796):353–357. doi: 10.1038/289353a0. [DOI] [PubMed] [Google Scholar]
  31. Caspersson T. O. Quantitative tumor cytochemistry--G.H.A. Clowes Memorial Lecture. Cancer Res. 1979 Jul;39(7 Pt 1):2341–2345. [PubMed] [Google Scholar]
  32. Caspersson T., Zech L., Johansson C. Differential binding of alkylating fluorochromes in human chromosomes. Exp Cell Res. 1970 Jun;60(3):315–319. doi: 10.1016/0014-4827(70)90523-9. [DOI] [PubMed] [Google Scholar]
  33. Cifone M. A., Fidler I. J. Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms. Proc Natl Acad Sci U S A. 1981 Nov;78(11):6949–6952. doi: 10.1073/pnas.78.11.6949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Costa A., Mazzini G., Del Bino G., Silvestrini R. DNA content and kinetic characteristics of non-Hodgkin's lymphoma: determined by flow cytometry and autoradiography. Cytometry. 1981 Nov;2(3):185–188. doi: 10.1002/cyto.990020310. [DOI] [PubMed] [Google Scholar]
  35. Cowell J. K., Wigley C. B. Changes in DNA content during in vitro transformation of mouse salivary gland epithelium. J Natl Cancer Inst. 1980 Jun;64(6):1443–1449. doi: 10.1093/jnci/64.6.1443. [DOI] [PubMed] [Google Scholar]
  36. Dahlin D. C. Pathology of osteosarcoma. Clin Orthop Relat Res. 1975 Sep;(111):23–32. doi: 10.1097/00003086-197509000-00004. [DOI] [PubMed] [Google Scholar]
  37. Dalla-Favera R., Bregni M., Erikson J., Patterson D., Gallo R. C., Croce C. M. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci U S A. 1982 Dec;79(24):7824–7827. doi: 10.1073/pnas.79.24.7824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. De Reuck J., Sieben G., De Coster W., Roels H., Eecken H. V. Cytophotometric DNA determination in human oligodendroglial tumours. Histopathology. 1980 Mar;4(2):225–232. doi: 10.1111/j.1365-2559.1980.tb02915.x. [DOI] [PubMed] [Google Scholar]
  39. Dembo A. J., Bush R. S. Current concepts in cancer: ovary--treatment of stages III and IV. Choice of postoperative therapy based on prognostic factors. Int J Radiat Oncol Biol Phys. 1982 May;8(5):893–897. doi: 10.1016/0360-3016(82)90096-7. [DOI] [PubMed] [Google Scholar]
  40. Diamond L. W., Bearman R. M., Berry P. K., Mills B. J., Nathwani B. N., Weisenburger D. D., Winberg C. D., Teplitz R. L., Rappaport H. Prolymphocytic leukemia: flow microfluorometric, immunologic, and cytogenetic observations. Am J Hematol. 1980;9(3):319–330. doi: 10.1002/ajh.2830090311. [DOI] [PubMed] [Google Scholar]
  41. Diamond L. W., Braylan R. C. Flow analysis of DNA content and cell size in non-Hodgkin's lymphoma. Cancer Res. 1980 Mar;40(3):703–712. [PubMed] [Google Scholar]
  42. Diamond L. W., Nathwani B. N., Rappaport H. Flow cytometry in the diagnosis and classification of malignant lymphoma and leukemia. Cancer. 1982 Sep 15;50(6):1122–1135. doi: 10.1002/1097-0142(19820915)50:6<1122::aid-cncr2820500616>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  43. Falor W. H., Ward R. M. Prognosis in well differentiated noninvasive carcinoma of the bladder based on chromosomal analysis. Surg Gynecol Obstet. 1977 Apr;144(4):515–518. [PubMed] [Google Scholar]
  44. Feichter G. E., Höffken H., Heep J., Haag D., Heberling D., Brandt H., Rummel H., Goerttler K. DNA-flow-cytometric measurements on the normal, atrophic, hyperplastic and neoplastic human endometrium. Virchows Arch A Pathol Anat Histopathol. 1982;398(1):53–65. doi: 10.1007/BF00585613. [DOI] [PubMed] [Google Scholar]
  45. Fossa S. D., Kaalhus O., Scott-Knudsen O. The clinical and histopathological significance of Feulgen DNA-values in transitional cell carcinoma of the human urinary bladder. Eur J Cancer. 1977 Oct;13(10):1155–1162. doi: 10.1016/0014-2964(77)90015-9. [DOI] [PubMed] [Google Scholar]
  46. Fosså S. D., Thorud E., Vaage S., Shoaib M. C. DNA cytometry of primary breast cancer. Comparison of microspectrophotometry and flow cytometry, and different preparation methods for flow cytometric measurements. Acta Pathol Microbiol Immunol Scand A. 1983 Jul;91(4):235–243. [PubMed] [Google Scholar]
  47. Friedlander M. L., Hedley D. W., Taylor I. W., Russell P., Coates A. S., Tattersall M. H. Influence of cellular DNA content on survival in advanced ovarian cancer. Cancer Res. 1984 Jan;44(1):397–400. [PubMed] [Google Scholar]
  48. Friedlander M. L., Russell P., Taylor I. W., Hedley D. W., Tattersall M. H. Flow cytometric analysis of cellular DNA content as an adjunct to the diagnosis of ovarian tumours of borderline malignancy. Pathology. 1984 Jul;16(3):301–306. doi: 10.3109/00313028409068541. [DOI] [PubMed] [Google Scholar]
  49. Friedlander M. L., Taylor I. W., Russell P., Musgrove E. A., Hedley D. H., Tattersall M. H. Ploidy as a prognostic factor in ovarian cancer. Int J Gynecol Pathol. 1983;2(1):55–63. doi: 10.1097/00004347-198301000-00005. [DOI] [PubMed] [Google Scholar]
  50. Friedlander M. L., Taylor I. W., Russell P., Tattersall M. H. Cellular DNA content--a stable feature in epithelial ovarian cancer. Br J Cancer. 1984 Feb;49(2):173–179. doi: 10.1038/bjc.1984.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Fu Y. S., Reagan J. W., Fu A. S., Janiga K. E. Adenocarcinoma and mixed carcinoma of the uterine cervix. II. Prognostic value of nuclear DNA analysis. Cancer. 1982 Jun 15;49(12):2571–2577. doi: 10.1002/1097-0142(19820615)49:12<2571::aid-cncr2820491226>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  52. Fu Y. S., Reagan J. W., Hsiu J. G., Storaasli J. P., Wentz W. B. Adenocarcinoma and mixed carcinoma of the uterine cervix. I. A. clinicopathologic study. Cancer. 1982 Jun 15;49(12):2560–2570. doi: 10.1002/1097-0142(19820615)49:12<2560::aid-cncr2820491225>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  53. Garson O. M. 3. The value of chromosome studies in the classification and management of the leukemias. Pathology. 1982 Jul;14(3):291–294. doi: 10.3109/00313028209061379. [DOI] [PubMed] [Google Scholar]
  54. George D. L., Francke U. Gene dose effect: regional mapping of human nuceloside phosphorylase on chromosome 14. Science. 1976 Nov 19;194(4267):851–852. doi: 10.1126/science.824731. [DOI] [PubMed] [Google Scholar]
  55. Gustafson H., Tribukait B., Brehmer-Andersson E. Detection of different DNA stem cell lines in a case of human bladder carcinoma. Acta Pathol Microbiol Scand A. 1981 Mar;89(2):133–135. doi: 10.1111/j.1699-0463.1981.tb00199.x. [DOI] [PubMed] [Google Scholar]
  56. Gustafson H., Tribukait B., Esposti P. L. DNA pattern, histological grade and multiplicity related to recurrence rate in superficial bladder tumours. Scand J Urol Nephrol. 1982;16(2):135–139. doi: 10.3109/00365598209179742. [DOI] [PubMed] [Google Scholar]
  57. Gustafson H., Tribukait B., Esposti P. L. DNA profile and tumour progression in patients with superficial bladder tumours. Urol Res. 1982 Feb;10(1):13–18. doi: 10.1007/BF00256518. [DOI] [PubMed] [Google Scholar]
  58. Gustafson H., Tribukait B., Esposti P. L. The prognostic value of DNA analysis in primary carcinoma in situ of the urinary bladder. Scand J Urol Nephrol. 1982;16(2):141–146. doi: 10.3109/00365598209179743. [DOI] [PubMed] [Google Scholar]
  59. Hansson J., Tribukait B., Lewensohn R., Ringborg U. Flow cytofluorometric DNA analyses of metastases of human malignant melanomas. Anal Quant Cytol. 1982 Jun;4(2):99–104. [PubMed] [Google Scholar]
  60. Hart W. R. Ovarian epithelial tumors of borderline malignancy (carcinomas of low malignant potential). Hum Pathol. 1977 Sep;8(5):541–549. doi: 10.1016/s0046-8177(77)80114-7. [DOI] [PubMed] [Google Scholar]
  61. Hedley D. W., Friedlander M. L., Taylor I. W., Rugg C. A., Musgrove E. A. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem. 1983 Nov;31(11):1333–1335. doi: 10.1177/31.11.6619538. [DOI] [PubMed] [Google Scholar]
  62. Henry W. M., Didolkar M. S., Lopez R., Tomei L. D. Tumor cell karyotypes in malignant melanoma. J Surg Oncol. 1979;11(1):31–38. doi: 10.1002/jso.2930110107. [DOI] [PubMed] [Google Scholar]
  63. Izuo M., Okagaki T., Richart R. M., Lattes R. DNA content in "apocrine metaplasia" of fibrocystic disease of the breast. Cancer. 1971 Mar;27(3):643–650. doi: 10.1002/1097-0142(197103)27:3<643::aid-cncr2820270320>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  64. Izuo M., Okagaki T., Richart R. M., Lattes R. Nuclear DNA content in hyperplastic lesions of cystic disease of the breast with special reference to malignant alteration. Cancer. 1971 Sep;28(3):620–627. doi: 10.1002/1097-0142(197109)28:3<620::aid-cncr2820280314>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  65. Jakobsen A., Kristensen P. B., Poulsen H. K. Flow cytometric classification of biopsy specimens from cervical intraepithelial neoplasia. Cytometry. 1983 Sep;4(2):166–169. doi: 10.1002/cyto.990040210. [DOI] [PubMed] [Google Scholar]
  66. Jakobsen A., Nielsen K. V., Rønne M. DNA distribution and chromosome number in human cervical carcinoma. Anal Quant Cytol. 1983 Mar;5(1):13–18. [PubMed] [Google Scholar]
  67. Jakobsen A. Ploidy level and short-time prognosis of early cervix cancer. Radiother Oncol. 1984 Jan;1(3):271–275. doi: 10.1016/s0167-8140(84)80010-9. [DOI] [PubMed] [Google Scholar]
  68. Jakobsen A. The use of trout erythrocytes and human lymphocytes for standardization in flow cytometry. Cytometry. 1983 Sep;4(2):161–165. doi: 10.1002/cyto.990040209. [DOI] [PubMed] [Google Scholar]
  69. Kajikawa H., Kawamoto K., Herz F., Wolley R. C., Hirano A., Koss L. G. Flow-through cytometry of meningiomas and cultured meningioma cells. Acta Neuropathol. 1978 Dec 15;44(3):183–187. doi: 10.1007/BF00691065. [DOI] [PubMed] [Google Scholar]
  70. Kawamoto K., Herz F., Wolley R. C., Hirano A., Kajikawa H., Koss L. G. Flow cytometric analysis of the DNA distribution in human brain tumors. Acta Neuropathol. 1979 Apr 12;46(1-2):39–44. doi: 10.1007/BF00684802. [DOI] [PubMed] [Google Scholar]
  71. Kovacs G. Abnormalities of chromosome No. 1 in human solid malignant tumours. Int J Cancer. 1978 Jun 15;21(6):688–694. doi: 10.1002/ijc.2910210604. [DOI] [PubMed] [Google Scholar]
  72. Kraemer P. M., Petersen D. F., Van Dilla M. A. DNA constancy in heteroploidy and the stem line theory of tumors. Science. 1971 Nov 12;174(4010):714–717. doi: 10.1126/science.174.4010.714. [DOI] [PubMed] [Google Scholar]
  73. Kreicbergs A., Boquist L., Borssén B., Larsson S. E. Prognostic factors in chondrosarcoma: a comparative study of cellular DNA content and clinicopathologic features. Cancer. 1982 Aug 1;50(3):577–583. doi: 10.1002/1097-0142(19820801)50:3<577::aid-cncr2820500332>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  74. Kreicbergs A., Broström L. A., Cewrien G., Einhorn S. Cellular DNA content in human osteosarcoma: aspects on diagnosis and prognosis. Cancer. 1982 Dec 1;50(11):2476–2481. doi: 10.1002/1097-0142(19821201)50:11<2476::aid-cncr2820501136>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  75. Krontiris T. G. The emerging genetics of human cancer. N Engl J Med. 1983 Aug 18;309(7):404–409. doi: 10.1056/NEJM198308183090704. [DOI] [PubMed] [Google Scholar]
  76. Kute T. E., Muss H. B., Anderson D., Crumb K., Miller B., Burns D., Dube L. A. Relationship of steroid receptor, cell kinetics, and clinical status in patients with breast cancer. Cancer Res. 1981 Sep;41(9 Pt 1):3524–3529. [PubMed] [Google Scholar]
  77. Laerum O. D., Farsund T. Clinical application of flow cytometry: a review. Cytometry. 1981 Jul;2(1):1–13. doi: 10.1002/cyto.990020102. [DOI] [PubMed] [Google Scholar]
  78. Lamb D. Correlation of chromosome counts with histological appearances and prognosis in transitional-cell carcinoma of bladder. Br Med J. 1967 Feb 4;1(5535):273–277. doi: 10.1136/bmj.1.5535.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Latreille J., Barlogie B., Dosik G., Johnston D. A., Drewinko B., Alexanian R. Cellular DNA content as a marker of human multiple myeloma. Blood. 1980 Mar;55(3):403–408. [PubMed] [Google Scholar]
  80. Lehmann J., Krug H. Flow-through fluorocytophotometry of different brain tumours. Acta Neuropathol. 1980;49(2):123–132. doi: 10.1007/BF00690752. [DOI] [PubMed] [Google Scholar]
  81. Lewensohn R., Tribukait B., Hansson J. DNA content of human myeloma cells. Eur J Cancer Clin Oncol. 1983 Jan;19(1):59–63. doi: 10.1016/0277-5379(83)90399-1. [DOI] [PubMed] [Google Scholar]
  82. Lewis P. D. A cytophotometric study of benign and malignant phaeochromocytomas. Virchows Arch B Cell Pathol. 1971;9(4):371–376. doi: 10.1007/BF02894059. [DOI] [PubMed] [Google Scholar]
  83. Little C. D., Nau M. M., Carney D. N., Gazdar A. F., Minna J. D. Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature. 1983 Nov 10;306(5939):194–196. doi: 10.1038/306194a0. [DOI] [PubMed] [Google Scholar]
  84. Look A. T., Melvin S. L., Williams D. L., Brodeur G. M., Dahl G. V., Kalwinsky D. K., Murphy S. B., Mauer A. M. Aneuploidy and percentage of S-phase cells determined by flow cytometry correlate with cell phenotype in childhood acute leukemia. Blood. 1982 Oct;60(4):959–967. [PubMed] [Google Scholar]
  85. MEEK E. S. The cellular distribution of deoxyribonucleic acid in primary and secondary growths of human breast cancer. J Pathol Bacteriol. 1961 Jul;82:167–176. doi: 10.1002/path.1700820120. [DOI] [PubMed] [Google Scholar]
  86. Mitelman F., Levan G. Clustering of aberrations to specific chromosomes in human neoplasms. II. A survey of 287 neoplasms. Hereditas. 1976 Jun 14;82(2):167–174. doi: 10.1111/j.1601-5223.1976.tb01553.x. [DOI] [PubMed] [Google Scholar]
  87. Mørk S. J., Laerum O. D. Modal DNA content of human intracranial neoplasms studied by flow cytometry. J Neurosurg. 1980 Aug;53(2):198–204. doi: 10.3171/jns.1980.53.2.0198. [DOI] [PubMed] [Google Scholar]
  88. Ng A. B., Atkin N. B. Histological cell type and DNA value in the prognosis of squamous cell cancer of uterine cervix. Br J Cancer. 1973 Oct;28(4):322–331. doi: 10.1038/bjc.1973.155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Nowell P. C. The clonal evolution of tumor cell populations. Science. 1976 Oct 1;194(4260):23–28. doi: 10.1126/science.959840. [DOI] [PubMed] [Google Scholar]
  90. Ono S. Genetic implication of karyological instability of malignant somatic cells. Physiol Rev. 1971 Jul;51(3):496–526. doi: 10.1152/physrev.1971.51.3.496. [DOI] [PubMed] [Google Scholar]
  91. Owerbach D., Bell G. I., Rutter W. J., Shows T. B. The insulin gene is located on chromosome 11 in humans. Nature. 1980 Jul 3;286(5768):82–84. doi: 10.1038/286082a0. [DOI] [PubMed] [Google Scholar]
  92. Owerbach D., Rutter W. J., Martial J. A., Baxter J. D., Shows T. B. Genes for growth hormone, chorionic somatommammotropin, and growth hormones-like gene on chromosome 17 in humans. Science. 1980 Jul 11;209(4453):289–292. doi: 10.1126/science.7384802. [DOI] [PubMed] [Google Scholar]
  93. Ołszewski W., Darzynkiewicz Z., Claps M. L., Melamed M. R. Flow cytometry of lung carcinoma: a comparison of DNA stemline and cell cycle distribution with histology. Anal Quant Cytol. 1982 Jun;4(2):90–98. [PubMed] [Google Scholar]
  94. Perez D. J., Taylor I. W., Milthorpe B. K., McGovern V. J., Tattersall M. H. Identification and quantitation of tumour cells in cell suspensions: a comparison of cytology and flow cytometry. Br J Cancer. 1981 Apr;43(4):526–531. doi: 10.1038/bjc.1981.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Pulciani S., Santos E., Lauver A. V., Long L. K., Aaronson S. A., Barbacid M. Oncogenes in solid human tumours. Nature. 1982 Dec 9;300(5892):539–542. doi: 10.1038/300539a0. [DOI] [PubMed] [Google Scholar]
  96. Raber M. N., Barlogie B., Latreille J., Bedrossian C., Fritsche H., Blumenschein G. Ploidy, proliferative activity and estrogen receptor content in human breast cancer. Cytometry. 1982 Jul;3(1):36–41. doi: 10.1002/cyto.990030109. [DOI] [PubMed] [Google Scholar]
  97. Rechavi G., Givol D., Canaani E. Activation of a cellular oncogene by DNA rearrangement: possible involvement of an IS-like element. Nature. 1982 Dec 16;300(5893):607–611. doi: 10.1038/300607a0. [DOI] [PubMed] [Google Scholar]
  98. Rognum T. O., Thorud E., Elgjo K., Brandtzaeg P., Orjasaeter H., Nygaard K. Large-bowel carcinomas with different ploidy, related to secretory component, IgA, and CEA in epithelium and plasma. Br J Cancer. 1982 Jun;45(6):921–934. doi: 10.1038/bjc.1982.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Rotman M., John M., Boyce J. Prognostic factors in cervical carcinoma: implications in staging and management. Cancer. 1981 Jul 15;48(2 Suppl):560–567. doi: 10.1002/1097-0142(19810715)48:1+<560::aid-cncr2820481320>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  100. Rowley J. D. Chromosomes in leukemia and lymphoma. Semin Hematol. 1978 Jul;15(3):301–319. [PubMed] [Google Scholar]
  101. Rönström L., Tribukait B., Esposti P. L. DNA pattern and cytological findings in fine-needle aspirates of untreated prostatic tumors. A flow-cytofluorometric study. Prostate. 1981;2(1):79–88. doi: 10.1002/pros.2990020108. [DOI] [PubMed] [Google Scholar]
  102. Sachs L. Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia. Nature. 1978 Aug 10;274(5671):535–539. doi: 10.1038/274535a0. [DOI] [PubMed] [Google Scholar]
  103. Sakurai M., Sandberg A. A. Prognosis of acute myeloblastic leukemia: chromosomal correlation. Blood. 1973 Jan;41(1):93–104. [PubMed] [Google Scholar]
  104. Sandberg A. A. Chromosome markers and progression in bladder cancer. Cancer Res. 1977 Aug;37(8 Pt 2):2950–2956. [PubMed] [Google Scholar]
  105. Schwabe H. W., Adolphs H. D., Vogel J. Flow-cytophotometric studies in renal carcinoma. Urol Res. 1983;11(3):121–125. doi: 10.1007/BF00257716. [DOI] [PubMed] [Google Scholar]
  106. Shackney S. E., Erickson B. W., Skramstad K. S. The T-lymphocyte as a diploid reference standard for flow cytometry. Cancer Res. 1979 Nov;39(11):4418–4422. [PubMed] [Google Scholar]
  107. Spratt J. S., Jr, Spjut H. J. Prevalence and prognosis of individual clinical and pathologic variables associated with colorectal carcinoma. Cancer. 1967 Nov;20(11):1976–1985. doi: 10.1002/1097-0142(196711)20:11<1976::aid-cncr2820201125>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  108. Spriggs A. I., Bowey C. E., Cowdell R. H. Chromosomes of precancerous lesions of thecervix uteri. New data and a review. Cancer. 1971 May;27(5):1239–1254. doi: 10.1002/1097-0142(197105)27:5<1239::aid-cncr2820270532>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  109. Søndergaard K., Larsen J. K., Møller U., Christensen I. J., Hou-Jensen K. DNA ploidy-characteristics of human malignant melanoma analysed by flow cytometry and compared with histology and clinical course. Virchows Arch B Cell Pathol Incl Mol Pathol. 1983;42(1):43–52. doi: 10.1007/BF02890369. [DOI] [PubMed] [Google Scholar]
  110. Tabin C. J., Bradley S. M., Bargmann C. I., Weinberg R. A., Papageorge A. G., Scolnick E. M., Dhar R., Lowy D. R., Chang E. H. Mechanism of activation of a human oncogene. Nature. 1982 Nov 11;300(5888):143–149. doi: 10.1038/300143a0. [DOI] [PubMed] [Google Scholar]
  111. Tavares A. S., Costa J., de Carvalho A., Reis M. Tumour ploidy and prognosis in carcinomas of the bladder and prostate. Br J Cancer. 1966 Sep;20(3):438–441. doi: 10.1038/bjc.1966.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Tavares A. S. Ploidy and histological types of mammary carcinomas. Eur J Cancer. 1968 Jan;3(6):449–455. doi: 10.1016/0014-2964(68)90081-9. [DOI] [PubMed] [Google Scholar]
  113. Taylor I. W. A rapid single step staining technique for DNA analysis by flow microfluorimetry. J Histochem Cytochem. 1980 Sep;28(9):1021–1024. doi: 10.1177/28.9.6157714. [DOI] [PubMed] [Google Scholar]
  114. Taylor I. W., Milthorpe B. K. An evaluation of DNA fluorochromes, staining techniques, and analysis for flow cytometry. I. Unperturbed cell populations. J Histochem Cytochem. 1980 Nov;28(11):1224–1232. doi: 10.1177/28.11.6159392. [DOI] [PubMed] [Google Scholar]
  115. Taylor I. W., Musgrove E. A., Friedlander M. L., Foo M. S., Hedley D. W. The influence of age on the DNA ploidy levels of breast tumours. Eur J Cancer Clin Oncol. 1983 May;19(5):623–628. doi: 10.1016/0277-5379(83)90178-5. [DOI] [PubMed] [Google Scholar]
  116. Tribukait B., Gustafson H., Esposti P. L. The significance of ploidy and proliferation in the clinical and biological evaluation of bladder tumours: a study of 100 untreated cases. Br J Urol. 1982 Apr;54(2):130–135. doi: 10.1111/j.1464-410x.1982.tb13536.x. [DOI] [PubMed] [Google Scholar]
  117. Tribukait B., Hammarberg C., Rubio C. Ploidy and proliferation patterns in colo-rectal adenocarcinomas related to Dukes' classification and to histopathological differentiation. A flow-cytometric DNA study. Acta Pathol Microbiol Immunol Scand A. 1983 Mar;91(2):89–95. [PubMed] [Google Scholar]
  118. Verma R. S., Dosik H. Recent advances in detecting human chromosomal abnormalities by various banding techniques. Pathol Annu. 1982;17(Pt 2):261–286. [PubMed] [Google Scholar]
  119. Vindeløv L. L., Hansen H. H., Christensen I. J., Spang-Thomsen M., Hirsch F. R., Hansen M., Nissen N. I. Clonal heterogeneity of small-cell anaplastic carcinoma of the lung demonstrated by flow-cytometric DNA analysis. Cancer Res. 1980 Nov;40(11):4295–4300. [PubMed] [Google Scholar]
  120. Wake N., Hreshchyshyn M. M., Piver S. M., Matsui S., Sandberg A. A. Specific cytogenetic changes in ovarian cancer involving chromosomes 6 and 14. Cancer Res. 1980 Dec;40(12):4512–4518. [PubMed] [Google Scholar]
  121. Weiss R. R., Richart R. M., Okagaki T., Cottral G. A. DNA content of mucinous tumors of the ovary. Am J Obstet Gynecol. 1969 Feb 1;103(3):409–424. doi: 10.1016/0002-9378(69)90501-8. [DOI] [PubMed] [Google Scholar]
  122. Welch W. R., Fu Y. S., Robboy S. J., Herbst A. L. Nuclear DNA content of clear cell adenocarcinoma of the vagina and cervix and its relationship to prognosis. Gynecol Oncol. 1983 Apr;15(2):230–238. doi: 10.1016/0090-8258(83)90079-3. [DOI] [PubMed] [Google Scholar]
  123. Whang-Peng J., Canellos G. P., Carbone P. P., Tjio J. H. Clinical implications of cytogenetic variants in chronic myelocytic leukemia (CML). Blood. 1968 Nov;32(5):755–766. [PubMed] [Google Scholar]
  124. Whang-Peng J., Kao-Shan C. S., Lee E. C., Bunn P. A., Carney D. N., Gazdar A. F., Minna J. D. Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23). Science. 1982 Jan 8;215(4529):181–182. doi: 10.1126/science.6274023. [DOI] [PubMed] [Google Scholar]
  125. Whitmore W. F., Jr Proceedings: The natural history of prostatic cancer. Cancer. 1973 Nov;32(5):1104–1112. doi: 10.1002/1097-0142(197311)32:5<1104::aid-cncr2820320515>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  126. Wolley R. C., Schreiber K., Koss L. G., Karas M., Sherman A. DNA distribution in human colon carcinomas and its relationship to clinical behavior. J Natl Cancer Inst. 1982 Jul;69(1):15–22. [PubMed] [Google Scholar]
  127. Zetterberg A., Esposti P. L. Prognostic significance of nuclear DNA levels in prostatic carcinoma. Scand J Urol Nephrol Suppl. 1980;55:53–58. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES